Testing effectiveness (Phase 2)Ended earlyNCT00229749What this trial is testingStudy of AVI-4065 in Healthy Volunteers and Chronic Active HCV PatientsWho this might be right forHepatitis C Sarepta Therapeutics, Inc. 80
Not applicableUnknownNCT00160940What this trial is testingDifferential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral HepatitisWho this might be right forHepatitis CHepatitis BAutoimmune Hepatitis+2 more University Health Network, Toronto 200
Large-scale testing (Phase 3)Study completedNCT03578640What this trial is testingEight Weeks of Elbasvir/Grazoprevir in the Treatment of HCV Genotype 4Who this might be right forHepatitis C, Chronic King Fahad Medical City 30
Post-approval studies (Phase 4)Study completedNCT00241618What this trial is testingTiming and Duration of Acute Hepatitis C TreatmentWho this might be right forHepatitis C Ain Shams University 180
Not applicableStudy completedNCT00241943What this trial is testingA Video-Based HCV Curriculum for Active Injection Drug UsersWho this might be right forHepatitis COpiate Dependence Organization to Achieve Solutions in Substance Abuse (OASIS) 103
Post-approval studies (Phase 4)Not Yet RecruitingNCT07793643What this trial is testingAI-Powered Hepatitis C Single-Encounter Test-and-TreatWho this might be right forHEPATITIS C (HCV) Patrick Grace 35
Not applicableStudy completedNCT05067374What this trial is testingHepatitis C Screening Paired With MammographyWho this might be right forHepatitis CBreast Cancer University Hospital, Montpellier 1,500
Testing effectiveness (Phase 2)Study completedNCT04246723What this trial is testingEfficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Sofosbuvir in Treatment-naïve Patients With Chronic Hepatitis C Genotype 1Who this might be right forChronic Hepatitis c Genotype 1 R-Pharm 85
Testing effectiveness (Phase 2)WithdrawnNCT00895882What this trial is testingStudy to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN)Who this might be right forChronic Genotype 1 Hepatitis C Virus Infection Merck Sharp & Dohme LLC
Post-approval studies (Phase 4)Study completedNCT00087594What this trial is testingPEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program.Who this might be right forHepatitis C, Chronic Hoffmann-La Roche 48
Post-approval studies (Phase 4)Study completedNCT02786537What this trial is testingStudy of Oral Treatments for Hepatitis CWho this might be right forChronic Hepatitis C University of Florida 1,275
Post-approval studies (Phase 4)Study completedNCT00938860What this trial is testingSustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis CWho this might be right forHepatitis CLiver Transplantation Novartis Pharmaceuticals 92
Large-scale testing (Phase 3)Study completedNCT01389323What this trial is testingBMS-790052 (Daclatasvir) Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis CWho this might be right forHepatitis C Bristol-Myers Squibb 448
Not applicableUnknownNCT05503979What this trial is testingElimination of Hepatitis C Virus Among Users of SubstancesWho this might be right forHepatitis C in Substance Users Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 1,000
Testing effectiveness (Phase 2)UnknownNCT01024894What this trial is testingDose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to BitherapyWho this might be right forHepatitis C Cytheris SA 15
Large-scale testing (Phase 3)UnknownNCT01664845What this trial is testingEffects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin ResistanceWho this might be right forChronic Hepatitis cInsulin Resistance Kaohsiung Veterans General Hospital. 120
Testing effectiveness (Phase 2)Study completedNCT00606086What this trial is testingSafety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C InfectionWho this might be right forGenotype 1 Chronic Hepatitis C GlobeImmune 140
Post-approval studies (Phase 4)Ended earlyNCT03208127What this trial is testingDAA Treatment in Donor HCV-positive to Recipient HCV-negative Liver TransplantWho this might be right forEnd Stage Liver DiseaseHepatitis C Massachusetts General Hospital 33
Post-approval studies (Phase 4)Study completedNCT00001854What this trial is testingLong-Term Therapy With Ribavirin for Chronic Hepatitis CWho this might be right forChronic Hepatitis C National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 50
Early research (Phase 1)Study completedNCT02683005What this trial is testingStudy of Hepatitis C Treatment During PregnancyWho this might be right forHepatitis CPregnancy Catherine Chappell 9